October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures, and the company recommends that physicians do no perform new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).
Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.
October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Siemens Medical Solutions Molecular Imaging Division's Symbia E series single photon emission computed tomography (SPECT ...
October 15, 2007 - Low-dose coronary CT angiogram (CCTA) could be better for testing asymptomatic patients for heart attack risk, according to researchers at Cedars-Sinai Medical Center, Los Angeles, CA.
October 15, 2007 - Oncologists need to consider the affects on the cardiovascular system when treating early breast cancer, according to a review article in the Oct. 9 issue of the Journal of the American College of Cardiology.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 15, 2007 - Siemens Medical Solutions Molecular Imaging Division will introduce the new Symbia E series single ...
October 11, 2007 - GE Healthcare, a unit of General Electric Company, today announced that it has completed the ...
October 10, 2007 - Medtronic Inc. announced that an FDA advisory committee has recommended the Endeavor drug-eluting ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 9, 2007 - Luna Innovations Inc. has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corp. (Terumo CVS), in which Luna and Terumo CVS will market Luna’s EDAC (Emboli Detection and Classification) Quantifier, as part of Luna's strategy to expand its presence in the U.S.
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 15, 2007
